This is an outdated version published on 2026-07-24. Read the most recent version.

Diabetes mellitus type 2 post Covid 19

Authors

  • Regina Cruz Curiel Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0000-4357-2656
  • Valeria González García Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0002-0408-1218
  • Giselle Lugo Ambrosio Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0002-3583-020X
  • Zabdy Anahí Dimas Ibarra Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0009-8736-3181
  • David Pérez Becker Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0007-7554-1310
  • Josefina Reynoso Vázquez Department of Pharmacy and MSP Coordination at the (ICSA-UAEH) Institute of Health Sciences of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0002-9943-0881
  • Olga Rocío Flores Chávez Department of Nursing at the (ICSA-UAEH) Institute of Health Sciences at the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0001-9479-9834
  • Ana Yareli Escudero Castelán Department of Psychology at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0001-6466-1578
  • Julieta Aleli Izquierdo Vega Academic Division of Medicine and Master’s Program in Biomedical Sciences (ICSA-UAEH), Institute of Health Sciences at the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0002-9639-9524
  • Beatriz Adriana Vázquez Pérez Centro Universitario de Ciencias de a Salud [CUCS] Universidad de Guadalajara, Jalisco, México https://orcid.org/0009-0009-3268-3276
  • Jesús Carlos Ruvalcaba Ledezma 7Independent Researcher, Former Researcher, Academic Division of Medicine, UAEH-MSP, Mexico https://orcid.org/0000-0002-5593-3946

DOI:

https://doi.org/10.17140/phoj-11-770

Keywords:

COVID-19, Diabetes Mellitus Type 2

Abstract

Type 2 diabetes mellitus is a very common disease in Mexican society; it is difficult to control due to poor dietary habits and a lack of adequate treatment. In this article, we will discuss whether the COVID-19 virus is a trigger for type 2 diabetes mellitus. It is known that in some people, a COVID-19 infection can affect blood glucose levels, but is it really a trigger for developing diabetes?

Objective. To determine how type 2 diabetes mellitus might manifest as a post-COVID-19 condition. Methodology. An observational, descriptive, cross-sectional epidemiological study was conducted using a questionnaire created in Google Forms, administered to individuals who had contracted COVID-19 and who have been diagnosed with type 2 diabetes mellitus. Results.  The results of the survey administered to 38 people indicate that 94.7% of our sample population has type 2 diabetes mellitus. Furthermore, we found that the most common age was 76 years, accounting for 15.8% of the sample, while the least common age was 22 years, accounting for 1.6%. Upon questioning our participants, we discovered that 82.9% had been diagnosed with diabetes before the COVID-19 pandemic and that 78.9% contracted COVID-19 between 2020 and 2022. Conclusions. Type 2 diabetes mellitus is one of the leading causes of death in our country; a large portion of the population suffers from this disease from an early age, making it difficult to establish a link between type 2 diabetes mellitus and COVID-19 as a complication.

Downloads

Published

2026-07-24

Versions

How to Cite

Regina Cruz Curiel, Valeria González García, Giselle Lugo Ambrosio, Zabdy Anahí Dimas Ibarra, David Pérez Becker, Josefina Reynoso Vázquez, … Jesús Carlos Ruvalcaba Ledezma. (2026). Diabetes mellitus type 2 post Covid 19. Public Health - Open Journal, 11(1), 773. https://doi.org/10.17140/phoj-11-770

Issue

Vol. 11 No. 1 (2026): Volume 11 Issue 1 2026

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Public Health - Open Journal (PHOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.